Single, High-dose AmBisome to Reduce Excess mortality from Cryptococcal Meningitis
Our SHARE-CM
Project
Single, High-dose AmBisome to Reduce Excess mortality from Cryptococcal Meningitis
Project Overview
Project title: Single, High-dose AmBisome to Reduce Excess mortality from Cryptococcal Meningitis
Abbreviation: SHARE-CM
Start date: 01/09/2021 End date: 30/09/2026
The purpose of this project is to leverage individual and institutional experience in delivering the ACTA and AMBITION-cm short-course regimens for HIV-associated cryptococcal meningitis to facilitate widespread implementation across Botswana, Malawi, Uganda and Zimbabwe with the ultimate aim of reducing mortality from cryptococcal meningitis in real-world settings. SHARE-CM is co-funded by the Centers for Disease Control and Prevention (CDC).
Key Objectives
Improved in-country and international partnerships to support execution of HIV-associated fungal disease public health work.
Increased public awareness and knowledge of fungal diseases.
Increased provider awareness, knowledge and support for identifying and diagnosing fungal infections.
Improved treatment of HIV-associated fungal infections.
Team Members
Dr David Lawrence
Prof Tom Harrison (CSGUL)
Dr Eltas Dziwani (MLWT)
Professor David Meya (IDI)
Professor Joe Jarvis
Dr Tshepo Leeme (BHP)
Professor Henry Mwandumba(MLWT)
Dr Constantine Mutaba (UoZ)
Professor Nelesh Govender (WITS)
Professor Mosepele (BHP)
Dr Jane Gakuru (IDI)
Professor Chiratidzo Ndhlovu (UoZ)
Project Partners
Project Funders
We value your privacy.
The WITS Mycology website uses cookies to enhance your browsing experience, serve personalized ads or content and analyze our site traffic.
By continuing to browse our website, you consent to our use of cookies.